Your browser is no longer supported. Please, upgrade your browser.
Pacific Biosciences of California, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own6.80% Shs Outstand198.57M Perf Week-1.69%
Market Cap5.22B Forward P/E- EPS next Y-0.96 Insider Trans-1.00% Shs Float185.52M Perf Month8.40%
Income-77.20M PEG- EPS next Q-0.46 Inst Own91.00% Short Float6.84% Perf Quarter-5.88%
Sales105.80M P/S49.34 EPS this Y130.50% Inst Trans11.25% Short Ratio6.39 Perf Half Y-19.55%
Book/sh1.30 P/B21.53 EPS next Y17.30% ROA-9.60% Target Price47.00 Perf Year244.28%
Cash/sh6.14 P/C4.56 EPS next 5Y-1.00% ROE-30.80% 52W Range7.91 - 53.69 Perf YTD7.90%
Dividend- P/FCF- EPS past 5Y19.10% ROI8.20% 52W High-48.48% Beta1.09
Dividend %- Quick Ratio25.80 Sales past 5Y-3.20% Gross Margin42.70% 52W Low249.68% ATR1.56
Employees412 Current Ratio26.20 Sales Q/Q78.90% Oper. Margin-69.40% RSI (14)42.55 Volatility4.77% 5.23%
OptionableYes Debt/Eq0.00 EPS Q/Q-37.90% Profit Margin-73.00% Rel Volume0.50 Prev Close27.99
ShortableYes LT Debt/Eq3.47 EarningsAug 03 AMC Payout- Avg Volume1.99M Price27.66
Recom2.40 SMA20-6.51% SMA50-7.22% SMA200-9.53% Volume552,228 Change-1.18%
Feb-11-21Upgrade Piper Sandler Neutral → Overweight $20 → $52
Nov-03-20Downgrade Piper Sandler Overweight → Neutral $12
Oct-02-20Upgrade JP Morgan Neutral → Overweight $15
Sep-09-20Initiated Morgan Stanley Equal-Weight $7
Jun-02-20Resumed Cantor Fitzgerald Overweight $5
Mar-09-20Resumed Cantor Fitzgerald Overweight $5
Oct-15-19Upgrade Piper Jaffray Neutral → Overweight $8
Apr-02-19Downgrade Stephens Overweight → Equal-Weight $4.50 → $8
Oct-19-18Initiated Cowen Outperform
Nov-03-17Downgrade First Analysis Sec Overweight → Equal-Weight $4
Sep-28-17Downgrade CL King Buy → Neutral
Nov-03-16Reiterated Cantor Fitzgerald Buy $18 → $15
Jun-27-16Initiated CL King Buy
Apr-15-16Initiated First Analysis Sec Overweight $11
Feb-04-16Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16Reiterated Cantor Fitzgerald Buy $11 → $18
Oct-23-15Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Initiated Cantor Fitzgerald Buy
Feb-04-15Reiterated Maxim Group Buy $10 → $11
Sep-26-13Reiterated Maxim Group Buy $4 → $8
Sep-21-21 09:18AM  
Sep-20-21 04:05PM  
Sep-03-21 09:00AM  
Sep-02-21 11:31AM  
Aug-23-21 10:11AM  
Aug-09-21 08:00AM  
Aug-05-21 12:30PM  
Aug-04-21 11:26AM  
Aug-03-21 05:25PM  
Jul-28-21 04:05PM  
Jul-27-21 03:03PM  
Jul-23-21 07:02AM  
Jul-20-21 10:49AM  
Jul-19-21 04:05PM  
Jul-12-21 07:34AM  
Jun-29-21 05:56PM  
Jun-25-21 02:27PM  
Jun-23-21 04:05PM  
Jun-11-21 04:05PM  
Jun-08-21 02:00AM  
May-29-21 06:45AM  
May-25-21 04:47PM  
May-21-21 04:05PM  
May-17-21 04:05PM  
May-04-21 09:00AM  
May-03-21 12:29PM  
Apr-30-21 01:22PM  
Apr-29-21 04:05PM  
Apr-27-21 04:30PM  
Apr-26-21 08:00AM  
Apr-24-21 12:40PM  
Apr-22-21 04:05PM  
Apr-15-21 04:05PM  
Apr-11-21 10:26AM  
Mar-25-21 10:46AM  
Mar-16-21 12:51PM  
Mar-12-21 11:30AM  
Mar-02-21 04:30PM  
Feb-26-21 04:04PM  
Feb-24-21 08:00AM  
Feb-19-21 09:50AM  
Feb-18-21 08:01AM  
Feb-12-21 12:08AM  
Feb-11-21 12:24PM  
Feb-10-21 09:31PM  
Feb-09-21 10:23AM  
Feb-05-21 05:00PM  
Feb-02-21 12:24PM  
Jan-29-21 04:15PM  
Jan-27-21 02:30PM  
Jan-26-21 11:05AM  
Jan-20-21 11:36AM  
Jan-13-21 12:19PM  
Jan-12-21 06:26PM  
Jan-11-21 07:45AM  
Jan-08-21 03:16PM  
Jan-07-21 09:13AM  
Jan-01-21 01:31AM  
Dec-31-20 05:00AM  
Dec-24-20 11:10AM  
Dec-23-20 07:29PM  
Dec-18-20 04:05PM  
Dec-16-20 08:00AM  
Dec-14-20 08:00AM  
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform; and a research collaboration with Rady Children's Institute for Genomic Medicine for whole genome sequencing platform. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENRY CHRISTIAN OPresident & CEOSep 16Sale26.9190,5202,435,893674,480Sep 17 04:53 PM
Ericson William W.DirectorMay 25Option Exercise4.7537,500178,00037,500May 26 08:50 PM
Ericson William W.DirectorMay 25Sale25.8937,500971,0580May 26 08:50 PM
Hunkapiller MichaelDirectorFeb 26Option Exercise6.36234,2461,490,2071,082,651Mar 02 08:31 PM
Hunkapiller MichaelDirectorFeb 26Sale31.02234,2467,265,866848,405Mar 02 08:31 PM
Hunkapiller MichaelDirectorFeb 25Option Exercise6.40339,3772,172,2911,187,782Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 25Sale32.33339,37710,972,944848,405Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 24Option Exercise6.05266,4271,613,0961,114,832Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 24Sale36.80266,4279,805,281848,405Feb 26 08:34 PM
Hunkapiller MichaelDirectorFeb 23Option Exercise5.97373,3212,227,8491,221,726Feb 24 08:50 PM
Hunkapiller MichaelDirectorFeb 23Sale34.88373,32113,022,317848,405Feb 24 08:50 PM
Hunkapiller MichaelDirectorFeb 22Option Exercise5.53229,1271,266,2511,077,532Feb 24 08:50 PM
Schaefer EricChief Accounting OfficerFeb 22Sale39.203,842150,60688,474Feb 24 08:21 PM
Hunkapiller MichaelDirectorFeb 22Sale39.14229,1278,967,407848,405Feb 24 08:50 PM
ORDONEZ KATHYDirectorFeb 16Option Exercise4.92185,879915,243242,646Feb 18 09:52 PM
ORDONEZ KATHYDirectorFeb 16Sale47.99220,77110,595,81021,875Feb 18 09:52 PM
Botstein DavidDirectorFeb 12Option Exercise4.42160,000706,800160,000Feb 17 09:15 PM
LIVINGSTON RANDALL SDirectorFeb 12Option Exercise4.3667,500294,40067,500Feb 17 09:17 PM
Botstein DavidDirectorFeb 12Sale49.62160,0007,939,7640Feb 17 09:15 PM
Shapiro LucyDirectorFeb 12Sale50.40101,6665,123,9660Feb 17 09:19 PM
LIVINGSTON RANDALL SDirectorFeb 12Sale48.0767,5003,244,4550Feb 17 09:17 PM
Hunkapiller MichaelDirectorJan 25Option Exercise6.14125,406769,993973,811Jan 27 05:07 PM
Hunkapiller MichaelDirectorJan 25Sale36.34125,4064,556,901848,405Jan 27 05:07 PM
Hunkapiller MichaelDirectorJan 22Option Exercise6.14150,857926,262999,262Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 22Sale36.77150,8575,547,490848,405Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 21Option Exercise3.31208,711691,4111,106,926Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 21Sale36.58258,5219,457,071848,405Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 20Option Exercise2.27215,026488,1091,113,241Jan 22 09:49 PM
Hunkapiller MichaelDirectorJan 20Sale39.19215,0268,426,269898,215Jan 22 09:49 PM
Hunkapiller MichaelDirectorDec 22Option Exercise3.01364,4511,096,9981,262,666Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 22Sale25.62364,4519,335,716898,215Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 21Option Exercise2.88335,549965,8771,233,764Dec 23 06:34 PM
Hunkapiller MichaelDirectorDec 21Sale23.00335,5497,718,327898,215Dec 23 06:34 PM
Hunkapiller MichaelDirectorNov 24Sale14.381,49221,4620Nov 25 04:46 PM
Hunkapiller MichaelDirectorNov 23Sale15.03251,8373,785,6141,492Nov 24 04:44 PM
Hunkapiller MichaelDirectorNov 20Sale15.11147,7992,233,538253,329Nov 24 04:44 PM
Hunkapiller MichaelDirectorNov 19Sale15.552,20134,226401,128Nov 20 05:16 PM
Hunkapiller MichaelDirectorNov 18Sale15.7138,381603,004403,329Nov 20 05:16 PM
Hunkapiller MichaelDirectorNov 16Sale15.8942,488675,347441,710Nov 18 04:05 PM
Hunkapiller MichaelDirectorNov 12Sale16.73200,0003,345,800484,198Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 11Sale16.46250,0004,116,000684,198Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 11Sale14.25195,6522,788,041898,215Nov 13 05:17 PM
Hunkapiller MichaelDirectorNov 10Sale14.251,304,34818,586,9591,093,867Nov 13 05:17 PM